Towards Healthcare

Diagnostic Testing Companies, Innovation and Product Evolution

Date : 29 September 2025

Top Companies in the Diagnostic Testing Market

Diagnostic Testing Market Companies

  • Abbott Laboratories
  • Roche Diagnostics
  • Siemens Healthineers
  • Danaher Corporation (Cepheid, Beckman Coulter)
  • Thermo Fisher Scientific
  • Bio-Rad Laboratories
  • QIAGEN N.V.
  • Quest Diagnostics
  • Laboratory Corporation of America (LabCorp)
  • PerkinElmer (Revvity)
  • Agilent Technologies
  • BD (Becton, Dickinson and Company)
  • Illumina, Inc.
  • Hologic, Inc.
  • Myriad Genetics, Inc.
  • Exact Sciences Corporation
  • Sysmex Corporation
  • BioMérieux SA
  • ARUP Laboratories
  • Invitae Corporation

Market Growth

The global diagnostic testing market size reached US$ 203.3 billion in 2024 and is anticipate to increase to US$  209.48 billion in 2025. By 2034, the market is forecasted to achieve a value of around US$ 274.53 billion, growing at a CAGR of 3.04%.

Diagnostic Testing Market Value Chain Analysis

R&D

  • Activities: Biomarker discovery, assay development, technology innovation (e.g., molecular diagnostics, AI integration).
  • Organizations: Diagnostic companies (Roche Diagnostics, Abbott, Thermo Fisher Scientific), biotech startups, academic research institutes, and public-private partnerships.

Clinical Trial and Approval

  • Activities: Clinical validation of diagnostic tests, safety and efficacy trials, regulatory submissions.
  • Organizations: Regulatory authorities (FDA in the U.S., EMA in Europe, CDSCO in India), clinical research organizations (IQVIA, Covance), hospitals, and academic medical centers conducting trials.

Patient Service and Support

  • Activities: Test administration, result interpretation, digital platforms for patient reporting, and aftercare support.
  • Organizations: Hospitals, clinics, diagnostic laboratories (Quest Diagnostics, LabCorp, SRL Diagnostics), telehealth platforms, and patient support groups offering education and counseling.

Latest Announcement by Industry Leaders

In August 2025, Audra Jones, Senior Vice President, North America, QuidelOrtho, stated that in order to increase access to high-quality diagnostic testing in community and rural hospitals across the United States, QuidelOrtho Corporation has started a Certified Analyzer Program. The program provides certified VITROSTM analyzers that provide award-winning service, quality results, and proven reliability at a fraction of the cost, and is specifically designed for clinics, physician office labs, and small hospitals with fewer than 100 beds.

Recent Developments in the Diagnostic Testing Market

  • In September 2025, Otsuka Pharmaceutical Co., Ltd. (Otsuka), a healthcare company, revealed the introduction of the new research facility, the Tokyo Laboratory, based within the Mitsui Link Lab.
  • In February 2025, DeepHealth's groundbreaking cloud-native operating system, DeepHealth OS, will enable new AI-powered radiology informatics and cancer screening solutions at ECR 2025 to address operational and clinical challenges. With a unified workspace designed for contemporary radiology, DeepHealth hopes to introduce its Diagnostic Suite to European clients, redefining the conventional Picture Archiving and Communication System (PACS), further integrating AI-based detection and diagnosis into interpretive workflows with SmartMammo, an end-to-end diagnostic SaaS solution for mammography.
  • In August 2025, an agreement was signed between M/s Primary Healthtech Put and the Technology Development Board (IDB), Department of Science and Technology, Government of India. The project is called "IoT-enabled Point-of-care Blood Testing Device for Affordable and Accessible Healthcare powered by AI/ML algorithms," and it was awarded to Ltd., New Delhi.

Become a valued research partner with us, please feel free to contact us at sales@towardshealthcare.com